Reckitt Benckiser Group plc
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex,…more
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex,…more
Latest RNS from Reckitt Benckiser Group plc
- buybackTransaction in Own Shares
- buybackTransaction in Own Shares
- interim_resultsResults for the Six Months Ended 30 June 2026
Analyst consensus: Buy
As of 22 Sept 2026, 19 analysts rate Reckitt Benckiser Group plc a Buy, with 74% buy ratings and a mean price target of 6,239p (range 5,352p–7,500p), +24% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 7,371p against a current price of 4,969p (+48%), based on EV/EBITDA.